UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus

Go back to UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus
(NYSE: UCB) Delayed: 35.51 -0.19 (0.53%)
Previous Close $35.70    52 Week High
Open $35.49    52 Week Low
Day High $35.74    P/E N/A 
Day Low $35.30    EPS
Volume 685,292